Ultrasound Board and Probe Repair Quality Agreement: Depot Deliverables and Clause Set

Direct Answer: Structuring an Ultrasound Repair Quality Agreement

When a healthcare facility, independent service organization (ISO), or equipment distributor contracts a depot to repair ultrasound printed circuit boards (PCBs) or transducers, a generic purchase order often leaves important evidence and escalation terms undefined. The FDA's Quality Management System Regulation (QMSR)—effective February 2, 2026—places the 21 CFR § 820.35(b) servicing-record requirement on manufacturers subject to Part 820. It does not automatically regulate every hospital or independent repair depot as a manufacturer. Even where the rule is not directly applicable, its six record fields and ISO 13485 servicing concepts provide a useful contract template.

A practical ultrasound repair quality agreement should combine two core elements and be adapted to the parties' roles, local law, and the specific device:

1. A Customer-to-Depot Deliverables Schedule: A concrete per-repair data package that the depot must produce before a serviced unit is released back to clinical inventory (intake identity confirmation, decontamination disclosure, component traceability, model-specific bench and real-machine test reports, named quality release authorization, and RMA warranty documentation).
2. An Ultrasound-Specific Clause Set: Contractual provisions governing the servicing-versus-remanufacturing boundary, unambiguous turnaround-time clock definitions, repeat-failure escalation thresholds, joint complaint handling/CAPA obligations, change notification rules, and record retention cadences.

+-----------------------------------------------------------------------------------+
|               ULTRASOUND DEPOT REPAIR QUALITY AGREEMENT ARCHITECTURE              |
+-----------------------------------------------------------------------------------+
| PER-REPAIR DELIVERABLES SCHEDULE      | CONTRACTUAL CLAUSE SET                     |
| 1. Intake Identity & Decon Disclosure | 1. Servicing vs Remanufacturing Boundary  |
| 2. Replacement Part Traceability Log  | 2. Turnaround Clock (Events, Pauses)      |
| 3. Model-Specific Real-Machine Test   | 3. 21 CFR 820.35(b) Servicing Records     |
| 4. QA Release Authorization & RMA     | 4. Repeat Failures, Complaints & CAPA     |
+-----------------------------------------------------------------------------------+

Prerequisites: Positioning Service Agreements Within the Quality Hierarchy

A service quality agreement for depot repair differs fundamentally from contract manufacturing or software vendor agreements. While general guidelines exist for CDMO quality agreement RACI matrices, specialized terms for cloud, AI, and cybersecurity testing vendors, and general frameworks for medical device CMO selection, an ultrasound repair agreement governs existing physical assets circulating through post-market maintenance workflows.

Before drafting a depot agreement, healthcare technology management (HTM) leaders and procurement teams should understand how the depot builds its internal quality management system by reviewing our guide on depot repair QMS for reusable capital equipment and reference the clinical evaluation rules in our guide on ultrasound probe repair vs replace decision frameworks.

What Deliverables Must the Depot Provide on Every Repair?

The core of the quality agreement is a per-repair deliverables schedule. A risk-based contract can require a Service Evidence Package before a repaired board or probe is accepted. The six artifacts below are a recommended template, not universal statutory fields.

[Intake Identity & Decon] ──> [Component Traceability Log] ──> [Real-Machine Test Record]
                                                                        │
[Warranty / RMA Cert]     <── [QA Release Authorization]   <────────────┘

Recommended Per-Repair Service Evidence Package

For each repair event, the customer can require a unified electronic package before acceptance or invoice approval:

1. Intake Identity & Symptom Baseline: Documenting the system model, serial number, OEM board/probe part number, hardware revision level, customer work order number, and reported clinical symptom code.
2. Decontamination Clearance & Secondary Bio-Sanitization Log: Providing dual evidence: a customer-signed decontamination clearance upon shipment, plus the depot's secondary bio-decontamination processing record detailing chemical agent, exposure time, and technician signature.
3. Component Traceability & Work Log: Itemizing all servicing actions executed, including component-level rework (e.g., replacement of failed high-voltage MOSFETs, analog multiplexers, or flex cable soldering) and a serialized replacement parts log recording part number, lot/serial number, and condition grade.
4. Model-Specific Test Data: Supplying the bench, compatible-host, image-performance, leak-integrity, or electrical-safety results applicable to the item and repair. Record tests that are not applicable with a reason; do not demand a chassis-level test as a universal loose-probe artifact.
5. Quality Release Authorization: A signed, dated release certificate executed by a designated Quality Assurance inspector confirming that the serviced unit complies with defined acceptance specifications.
6. Warranty & RMA Terms: Stating the warranty start event, duration, exclusions, remedies, freight allocation, and the process for obtaining an RMA if a claim arises.

Customer vs. Depot Operational RACI Matrix

To ensure seamless execution, the agreement should incorporate a Responsibility Assignment Matrix (RACI) clarifying roles across the repair lifecycle.

Defining the Turnaround Time (TAT) Clock to Prevent Disputes

Turnaround time disputes are among the most common operational friction points between healthcare organizations and depot facilities. Customers often measure TAT from the date a service request is logged, whereas depots measure TAT from the moment a physical board arrives at their loading dock.

To eliminate ambiguity, the quality agreement must define TAT using objective, event-driven clock triggers and explicit pause conditions.

[Clock Start: Receipt & Decon] ──> [Active Servicing / Bench Test] ──> [Clock Stop: QA Release & Ship]
                                              │
                                              └──> [PAUSE: Awaiting Customer Authorization]
                                              └──> [PAUSE: Awaiting Rare OEM Part Approval]

Turnaround Clock Clause Text

Clause 4.1 — Turnaround Time Definitions and Clock Triggers

(a) Clock Start: The Turnaround Time (TAT) clock shall commence strictly upon the fulfillment of all three of the following conditions ("Clock Start"): (i) physical receipt of the unit at the Depot facility, (ii) receipt of a completed and signed Decontamination Disclosure Form, and (iii) issuance of a written Intake Confirmation Notice by the Depot.

(b) Clock Stop: The TAT clock shall stop upon the completion of final Quality Release Authorization and the generation of the return carrier tracking identifier ("Clock Stop").

(c) Permissible Clock Pauses: The TAT clock shall be paused, and the elapsed time excluded from SLA calculations, only upon the occurrence of documented pause events ("Clock Pause"):

• Pause Event A (Customer Approval): Waiting for Customer authorization of a revised repair cost estimate exceeding the pre-approved threshold (clock pauses upon dispatch of estimate; resumes upon written customer approval).
• Pause Event B (Rare Component Lead Time): Waiting for customer-specified proprietary replacement components unavailable in standard depot inventory, provided the Depot issues written notice within 24 hours of diagnostic completion.

(d) SLA Targets: The parties shall insert the quoted target for the specific service category and define whether transit, customer holds, and parts waits are included. A provider's published target for one category must not be assumed for probes or other categories.

Defining the Servicing vs. Remanufacturing Boundary

A critical regulatory clause in any ultrasound repair quality agreement is establishing strict operational boundaries to prevent a third-party depot from inadvertently crossing from servicing into remanufacturing under FDA guidance.

Under the FDA's May 2024 guidance Remanufacturing of Medical Devices, servicing returns a finished device to the original equipment manufacturer's safety and performance specifications for its original intended use. Work that significantly changes performance, safety specifications, or intended use is remanufacturing. A remanufacturer assumes manufacturer obligations and must perform an activity-specific premarket analysis; a new 510(k) is not automatic in every case.

+-----------------------------------------------------------------------------------------+
|                  FDA SERVICING VS. REMANUFACTURING BOUNDARY MATRIX                      |
+------------------------------------+----------------------------------------------------+
| Permissible Servicing Activities   | Impermissible Remanufacturing Boundaries           |
| (Covered under Agreement)          | (Prohibited without Prior Clearance)               |
+------------------------------------+----------------------------------------------------+
| - Replacing failed ICs, capacitors,| - Altering acoustic stack geometry, PZT crystal    |
|   or relays with matching specs.   |   formulation, or matching layer material.         |
| - Repairing damaged flex cables,   | - Modifying beamformer FPGA firmware or operating  |
|   strain reliefs, or outer housings.|   system algorithms beyond OEM revisions.          |
| - Re-potting and re-sealing lens   | - Changing patient-contact acoustic lens material |
|   membranes using approved RTV.    |   to unvalidated biocompatible formulations.       |
| - Restoring original power supply  | - Re-labeling system model identifiers or changing |
|   voltage calibration tolerances.  |   intended diagnostic applications.                |
+------------------------------------+----------------------------------------------------+

Servicing Boundary Clause Text

Clause 5.2 — Servicing vs. Remanufacturing Limits

The Depot covenants that work under this Agreement shall remain within the authorized servicing scope and shall not significantly change the finished device's safety or performance specifications or intended use. Any proposed change to acoustic-stack materials, transducer array construction, or control firmware shall be placed on hold and routed for a separate, activity-specific regulatory assessment; customer authorization alone does not eliminate manufacturer or premarket obligations.

Using 21 CFR § 820.35(b) as a Servicing-Record Template

Under the FDA's QMSR, a manufacturer subject to Part 820 must record the six fields in 21 CFR § 820.35(b) for its servicing activities. Health systems and independent depots are not named in that sentence merely because they buy or perform a repair. A customer can nevertheless incorporate the same six fields into its contract as a clear minimum dataset.

21 CFR § 820.35(b) Fields Mandated for Regulated Manufacturers:
  ├── 1. Name of the serviced device
  ├── 2. UDI, UPC, or other device identifier
  ├── 3. Date the service was completed
  ├── 4. Individual(s) who serviced the device
  ├── 5. Description of the service performed
  └── 6. Any test and inspection data

The sixth field—any test and inspection data—is especially useful for an evidence-based depot contract. For a non-manufacturer depot, capture it because the agreement and the depot's QMS require it, not because the article assumes Part 820 automatically applies. The data should match the unit, authorized work, and defined acceptance criteria.

QMSR Record Clause Text

Clause 6.1 — Servicing Record Capture and Accessibility

(a) Required Record Fields: The Depot shall maintain detailed servicing records for every unit processed under this Agreement. Using the 21 CFR 820.35(b) dataset as the contractual baseline, each record shall capture: (i) device name, (ii) UDI, UPC, or other available identifier, (iii) service date, (iv) individual(s) performing the service, (v) service performed, and (vi) applicable test and inspection data.

(b) Retention & Access: The parties shall specify a retention period consistent with the customer's device-life policy, the depot's QMS, and any regulations applicable to the responsible entity. Records shall be made available to the Customer within the response time stated in the agreement; FDA access applies when the record holder is subject to FDA inspection authority.

Repeat Failures, Complaints, CAPA, Warranty, and RMA Terms

To protect clinical safety and equipment uptime, the quality agreement must incorporate clear clauses for managing repeat failures, handling post-servicing complaints, and executing return material authorizations (RMA).

[Serviced Board/Probe Installed] ──> [Failure within Agreed Warranty]
                                                  │
                                                  v
[Escalation Protocol Triggered] <── [RMA Issued; Loaner if Contracted]
             │
             v
[Joint CAPA Investigation under ISO 13485 Clause 7.5.4 / 8.5.2]

Technical Breakdown of Common Component Failure Modes

To evaluate depot diagnostic thoroughness, the agreement should mandate root-cause classification against established ultrasound component failure modes:

• Transducer Lens Delamination & Pinholes: Degradation of the RTV acoustic lens silicone layer, creating potential chemical fluid ingress risks during high-level disinfection and patient shock hazards.
• Piezoelectric Crystal Element Dropout: Fractured PZT acoustic elements resulting in vertical black signal dropouts on 2D B-mode imaging and distorted Doppler spectral sweeps.
• Strain Relief & Flex Cable Fatigue: Internal copper conductor micro-fractures inside the probe cable harness caused by mechanical bending, leading to intermittent signal noise when the cable is flexed.
• Beamformer High-Voltage Driver Breakdown: MOSFET or capacitor short circuits on the transmitter board causing high-voltage DC supply collapse (+100V/-100V rail failures) and system boot errors.
• Control Panel Logic & Touchscreen Controller Failure: Liquid spill ingress or bus communication timeouts resulting in frozen touch interfaces or corrupted serial bus commands.

Repeat Failure & Warranty Escalation Clause Text

Clause 7.3 — Repeat Failure Escalation and Corrective Action

(a) Repeat Failure Definition: Any repaired unit that experiences the same documented failure mode within the warranty or monitoring window specified in the order shall be classified as a "Repeat Failure."

(b) Escalation Protocol: Upon notification of a Repeat Failure, Depot shall:

• Issue an RMA within the contracted response target and provide a compatible loaner only when loaner service is included in the quote.
• Initiate a documented Root Cause Analysis (RCA) and, when the depot's QMS criteria are met, corrective action under its applicable procedure.
• Provide the Customer with a written investigation report within the response time negotiated for the service category.

(c) Complaint Cooperation: Depot shall notify the Customer within the contract's safety-notification window after discovering a servicing defect that may have contributed to an adverse event. The parties shall assign assessment and reporting responsibilities under 21 CFR Part 803 to the entities to which those duties actually apply.

Change Notification, Cyber-Hygiene, and Record Retention Clauses

The agreement should define which changes to replacement-part sourcing, sub-tier vendors, service location, or test methods require notice. If servicing involves media that may contain protected health information (PHI), the parties should determine their HIPAA roles, business-associate obligations, access limits, return, and sanitization requirements before shipment.

Clause 8.1 — Change Control Notification

Depot shall notify Customer in writing within the negotiated notice period before implementing a material change that can affect the contracted output, including: (i) critical sub-tier component suppliers, (ii) validated test methods or diagnostic software, or (iii) the servicing location. The parties should define emergency-change handling separately.

Clause 8.2 — Patient Data Protection & Cyber Sanitation

If a repaired ultrasound system or storage module may contain patient data or DICOM archives, Customer shall identify the permitted disposition and Depot shall follow the agreed media-handling and sanitization method, such as the applicable NIST SP 800-88 technique. Depot personnel shall not retain patient data outside authorized systems.

Clause 8.3 — Record Retention and Handover

Servicing, calibration, nonconformance, and inspection records generated under this Agreement shall be maintained in secure, backed-up media for the agreed retention period. The termination clause shall state the export format, transfer deadline, confidentiality controls, and which party remains record custodian.

Applying the Agreement to a Real Provider: Example Evidence Path

To understand how a buyer translates this clause set into an operational relationship with an independent depot provider, consider the technical workflow of Rongtao Medical.

Provider Context and Operating Scope

Guangzhou Rongtao Medical Technology Co., Ltd. (founded 2013, Guangzhou, China) operates as an independent multi-brand ultrasound repair and replacement-parts provider. Rongtao Medical is an independent third-party depot and is not an OEM, nor is it an OEM-authorized service center for GE, Philips, Siemens, Canon/Toshiba, Mindray, or other ultrasound manufacturers.

Mapping Published Capabilities to Quality Clauses

When structuring a service agreement with an independent depot, healthcare procurement teams can cross-reference provider-published capabilities against contract clauses:

1. Test Verification and Release Evidence: On the official Rongtao Medical process page, the company publishes a multi-step depot workflow. Rongtao states that repaired boards receive 48-hour real-machine QA and repaired probes are verified on a compatible live system. Buyers should request the exact unit-linked record available for the quoted job.
2. Turnaround and Warranty Parameters: Rongtao publishes a 5-to-8-business-day target for standard board repair; probe timing is quoted per probe, and warranty is typically 90 days with exact coverage depending on category and service. The signed quote should turn only the confirmed terms into enforceable clock, coverage, remedy, and freight provisions.
3. Chain of Custody and Logistics: Procurement teams should require tracked intake and return shipping, device identity at each handoff, packaging responsibilities, customs ownership, and loss/damage allocation in Schedule A. Verify any special logistics status directly rather than inferring it from marketing copy.
4. Technical Sourcing Frameworks: Buyers can review technical evidence reports, such as the multi-brand ultrasound board repair RFQ template, the guide on how to qualify an ultrasound probe repair provider, and the framework for evaluating a recurring multi-brand ultrasound maintenance repair partner.

By translating verified provider capabilities into a signed quality agreement, buyers can turn commercial claims into unit-linked deliverables. The contract may mirror 21 CFR 820.35(b)'s six fields without implying that the depot is automatically a QMSR-regulated manufacturer.

Frequently Asked Questions (FAQ)

What servicing records does the QMSR require for a repaired ultrasound device?

For manufacturers subject to Part 820, 21 CFR § 820.35(b) requires six fields: (1) device name, (2) UDI, UPC, or other identifier, (3) service date, (4) individual(s) performing service, (5) service performed, and (6) test and inspection data. A hospital or independent depot can adopt the same dataset contractually even when it is not itself subject to that manufacturer requirement.

How is turnaround time (TAT) defined in a repair quality agreement?

TAT should be defined using clear event triggers: clock starts upon physical receipt, decontamination clearance, and intake confirmation; clock stops upon final quality release and tracking number creation. Permissible pauses (such as awaiting customer budget approval or rare component lead time) must be explicitly listed with written notice requirements.

When does repairing an ultrasound probe become remanufacturing under FDA guidance?

Under FDA's May 2024 guidance and diagnostic ultrasound regulations, repair becomes remanufacturing if processing significantly alters safety, performance specs, acoustic output matrix, or intended use—such as modifying acoustic stack PZT crystals, changing patient-contact lens materials to unvalidated formulations, or altering core beamformer firmware.

How are temporary loaner probes or system boards handled under the agreement?

Loaner availability should never be assumed. If offered, the agreement should identify eligible models, dispatch target, fees, freight, decontamination responsibility, acceptance evidence, damage allocation, and return deadline. If no compatible loaner is available, the contract should state the alternative remedy.

Should a depot repair quality agreement include a 21 CFR Part 803 MDR clause?

It should include a safety-escalation clause, but reporting duties depend on whether an entity is a manufacturer, importer, or device user facility and on the event facts. The agreement should require prompt depot-to-customer notification within a negotiated safety window, preserve relevant evidence, and assign who performs the Part 803 assessment and any required report.